Effective treatment of a lymphocytic variant of hypereosinophilic syndrome with reslizumab

J Dtsch Dermatol Ges. 2019 Nov;17(11):1171-1173. doi: 10.1111/ddg.13926_g.

[Article in German]

Authors

Thomas Buttgereit¹, Hanna Bonnekoh¹, Martin K Church¹, Karl-Christian Bergmann¹, Frank Siebenhaar¹, Martin Metz¹

Affiliation

¹ Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.

PMID: 31765097
DOI: 10.1111/ddg.13926_g

No abstract available

Publication types

Letter